Keywords
How to Cite
Abstract
Acute myocardial infarction is necrosis of any myocardial mass due to ischemia. COVID-19 can be complicated by thrombosis and myocardial damage, which can lead to the deployment of a clinical picture similar to acute myocardial infarction. The material of this article is presented on the example of a clinical case. A woman aged 37 was diagnosed with an acute myocardial infarction, which later turned out to be a manifestation of a complicated course of coronavirus COVID-19 infection. This case drew attention to the absence of a clinical picture specific to this infection in the form of a damage to the respiratory system or intoxication. The case is also distinguished by the presence of a single uncharacteristic clinical manifestation of COVID-19 in the form of a cardiovascular event with elevations of the ST segment on the cardiogram and other objective data and additional research methods characteristic of acute myocardial infarction. The work also analyzed the pathogenetic mechanisms of acute myocardial infarction and cardiovascular complications of COVID-19, examined the general links of pathogenesis of these two pathological units and analyzed the causes of difficulties in their differential diagnosis. In this regard, there are unquestionably complications of differential diagnosis and the prescription of timely correct therapy. A deeper understanding of these data may improve the algorithms for diagnosing acute myocardial infarction and cardiovascular complications of COVID-19.
References
Spuntarelli, V, Lucian. i, M., Bentivegna, E., Marini, V, Falangon. e, F, Confort. I., G., ... Martelletti, P. (2020). COVID-19: is it just a lung disease? A case-based review. SN Compr Clin Med, 2020 Jul 28, 1–6.
Moore, J. B., June, C. H. (2020). Cytokine release syndrome in severe COVID-19. Science, 368(6490), 473–474.
Li, L., Zhou, Q., Xu, J. (2020). Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in Coronavirus Disease 2019. Biomed Res Int, 2020:7413673.
Unificovaniy klininchniy protocol ekstreno`i, pervino`I (spetsializovano`i) I tretyno`I(vysokospetsializovano`i) medychno`i dopomogy ta medychno`i reabilitatsi`i "Gostriy koronarniy syndrome z elevatsieyu segmenta ST". Nakaz MOZ Ukra`iny No. 455 [Unified clinical protocol of emergency, primary, secondary (specialized) and tertiary (highly specialized) care and medical rehabilitation "Acute coronary syndrome with ST segment elevations."Order of the Ministry of Health of Ukraine No. 455]. (02.07.2014)
Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., … Uriel, N. (2020). COVID-19 and cardiovascular disease. Circulation, 141, 1648–1655.
Imazio, M., Klingel, K., Kindermann, I., Brucato, A., De Rosa, F. G., Adler, Y., De Ferrarri, G. M. (2020). COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis. BMJ, 106(15), 1127-1131. doi: 10.1136/heartjnl-2020-317186.
Yueying Wang, Zhaojia Wang, Gary Tse, Lin Zhang, Elaine Y Wan, Yutao Guo,… , Tong Liu (2020). Cardiac arrhythmias in patients with COVID-19. J Arrhythm., 36(5), 827–836.
Yuki Nakamura, Masaru Shimizu, Taeka Yamaki, Kohsuke Kushimoto, Ayahiro Yamashita, KazumaHayase,…, Bon Ohta (2020). Myocardial injury in a patient with severe coronavirus disease: A case report. J Infect Chemother, S1341-321X(20)30343-3.
Jose, R.J., Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation., Lancet Respir Med, 8, e46-e47. doi: 10.1016/S2213-2600(20)30216-2.
Chen, C., Chen, C., Yan, J., Zhou, N., Zhao, J. P, Wan. g, D. W. (2020). Analysis of myocardial injury in patients with COVID?19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhong Hua Xin Xue Guan Bing Za Zhi, 48, E008. doi: 10.3760/cma.j.cn112148-20200225-00123.
Matthew, Z. T., Poh, C. M., Renia, L., MacAry, P. A., Lisa F.P.Ng (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology, 1-2.
Ali, A., Boutjdir, M., Aromolaran, A.S. (2018). Cardiolipotoxicity, inflammation, and arrhythmias: role for interleukin-6 molecular mechanisms. Front Physiol, 9, 1866.
Kozlov V. K. (2010). Tsitokinoterapiya: patogeneticheskaya napravlennost` pri infektsionnyh, zabolevaniyah I klinincheskaya effectivnost`: rukovodstvo dlya vrachey. [Cytokine Therapy: Pathogenetic Focus in Infectious Diseases and Clinical Effectiveness: A Guide for Physicians.] St. Petersburg: Alter Ego; 2010. p.148.
Dontsov, A. V. (2013). Effektivnost` dalargina v korrektsii tsitokinovogo profilya u bol`nyh IBS i metabolicheskim sindromom [Effectiveness of dalargin in cytokine profile correction in patients with CAD and metabolic syndrome.] Kursk scientific and practical bulletin "Human and his health", (1), p. 48–51.
Kishimoto, T., Akira, S., Taga T. (1992). IL-6 receptor and mechanism of signal transduction. International J Immunopharmacology, 14(3), 431–438. doi: 10.1016/0192-0561(92)90173-I.
Nishiga, M., Wang, D. W, Ha. n, Y, Lewi. s, D.B., Wu, J.C. (2020). COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol, 17(9), 543–558. s41569-020-0413-9.
Madjid, M., Safavi-Naeini, P., Solomon, S. D. & Vardeny, O. (2020). Potential effects of coronaviruseson the cardiovascular system: a review. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1286
Pavan, K., Bhatraju, Bijan J. Ghassemieh, Michelle Nichols, Richard Kim, Keith R. Jerome Arun, K. Nalla, … T. Eoin West (2020). COVID-19 in critically ill patients in the Seattle region – case series. N. Engl. J. Med, 382, 2012–2022.
Steven Siu-lung Li 1, Cheung-wah Cheng, Chiu-lai Fu, Yiu-han Chan, Man-po Lee, Johnny Waiman Chan, Siu-fung Yiu (2003). Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study. Circulation, 108, 1798–1803.
Rojulpote C, Gonuguntla K, Patil S, Bhattaru A, Bravo PE. (2020). COVID-19 and the Heart.Colomb Med (Cali), 30, 51(2), e4320.
Guido Tavazzi, Carlo Pellegrini, Marco Maurelli, Mirko Belliato, Fabio Sciutti , Andrea Bottazzi,…Eloisa Arbustin (2020). Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail, 2020:1828.
ESC Guidelines for the management of acute myocardial infarction in patients presenting withST-segment elevation (2017). Eur Heart J, 39(21), 119–177. doi: 10.1093/eurheartj/ehx393.
Sripal Bangalore, Atul Sharma, Alexander Slotwiner (2020). ST-Segment Elevation in Patientswith Covid-19 - A Case Series. N Engl J Med, 382, 2478–2480.
Yenercag, M., et al. (2020). Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19. J Electrocardiol, 62, 5-9. PMID: 32731139.
Tan, Z. C., Fu, L. H., Wang, D. D., Hong K. (2020). Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations. Zhonghua Xinxueguanbing Zazhi, 48, E005. doi: 10.3760/cma.j.issn.cn112148-20200213-00077.
Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., Jain, S. S., ... Uriel, N. (2020). Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation, 141(20), 1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941. PMID: 32200663.
Masataka Nishiga, Dao Wen Wang, Yaling Han, David B. Lewis, Joseph C. (2020). COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology, 17(9), 543-558. doi: 10.1038/s41569-020-0413-9. PMID: 32690910; PMCID: PMC7370876.
Stefanini, G. G., Montorfano, M., Trabattoni, D., Andreini, D., Ferrante, G., Ancona, M., … Chieff, A. (2020). ST-Elevation Myocardial Infarction in Patients With COVID-19. Circulation, 141, 2113–2116.
"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.
Copyright Agreement
1. This Agreement on the transfer of rights to use the work from the Co-authors to the publisher (hereinafter the Agreement) is concluded between all the Co-authors of the work, represented by the Corresponding Author, and Kharkiv National Medical University (hereinafter the University), represented by an authorized representative of the Editorial Board of scientific journals (hereinafter the Editorial Board).
2. This Agreement is an accession agreement within the meaning of clause 1 of Article 634 of the Civil Code of Ukraine: that is, a contract, "the terms of which are established by one of the parties in forms or other standard forms, which can be concluded only by joining the other party to the proposed contract as a whole. The other party cannot offer its terms of the contract." The party that established the terms of this contract is the University.
3. If there is more than one author, the authors choose the Corresponding Author, who communicates with the Editorial Board on his own behalf and on behalf of all Co-authors regarding the publication of a written work of a scientific nature (article or review, hereinafter referred to as the Work).
4. The contract begins from the moment of submission of the manuscript of the Work by the Corresponding Author to the Editorial Board, which confirms the following:
4.1. all Co-authors of the Work are familiar with and agree with its content, at all stages of reviewing and editing the manuscript and the existence of the published Work;
4.2. all Co-authors of the Work are familiar with and agree to the terms of this Agreement.
5. The published Work is in electronic form in public access on the websites of the University and any websites and electronic databases in which the Work is posted by the University and is available to readers under the terms of the "Creative Commons" license (Attribution NonCommercial Sharealike 4.0 International)" or more free licenses "Creative Commons 4.0".
6. The Corresponding Author transfers, and the University receives, the non-exclusive property right to use the Work by placing the latter on the University's websites for the entire term of copyright. The University participates in the creation of the final version of the Work by reviewing and editing the manuscript of the article or review provided to the Editorial Board by the Corresponding Author, translating the Work into any languages. For the participation of the University in the finalization of the Work, the Co-authors agree to pay the invoice issued to them by the University, if such payment is provided by the University. The size and procedure of such payment are not the subject of this contract.
7. The University has the right to reproduce the Work or its parts in electronic and printed forms, to make copies, permanent archival storage of the Work, distribution of the Work on the Internet, repositories, scientometric databases, commercial networks, including for monetary compensation from third parties.
8. The co-authors guarantee that the manuscript of the Work does not use works whose copyright belongs to third parties.
9. The authors of the Work guarantee that at the time of submission of the manuscript of the Work to the Editorial Board, the property rights to the Work belong only to them, neither in whole nor in part have they been transferred to anyone (not alienated), they are not the subject of a lien, litigation or claims by third parties.
10. The Work may not be posted on the University's website if it violates a person's right to the privacy of his personal and family life, harms public order and health.
11. The work may be withdrawn by the Editorial Board from the University websites, libraries and electronic databases where it was placed by the Editorial Board, in cases of detection of violations of the ethics of the authors and researchers, without any compensation for the losses of the Co-authors. At the time of submission of the manuscript to the Editorial Board and all stages of its editing and review, the manuscript must not have already been published or submitted to other editorial offices.
12. The right transferred under this Agreement extends to the territory of Ukraine and foreign countries.
13. The rights of Co-authors include the requirement to indicate their names on all copies of the Work or during any public use or public mention of the Work; the requirement to preserve the integrity of the Work; legal opposition to any distortion or other encroachment on the Work, which may harm the honor and reputation of the Co-authors.
14. Co-authors have the right to control their personal non-property rights by familiarizing themselves with the text (content) and form of the Work before its publication on the University's website, when transferring it to a printing company for reproduction or when using the Work in other ways.
15. The Co-authors, in addition to the property rights not transferred under this Agreement and taking into account the non-exclusive nature of the rights transferred under this Agreement, retain the property rights to finalize the Work and to use certain parts of the Work in other works created by the Co-authors.
16. The Co-authors are obliged to notify the Editorial Board of all errors in the Work, discovered by them independently after the publication of the Work, and to take all measures to eliminate such errors as soon as possible.
17. The University undertakes to indicate the names of the Co-authors on all copies of the Work during any public use of the Work. The list of Co-authors may be shortened according to the rules for the formation of bibliographic descriptions determined by the University or third parties.
18. The University undertakes not to violate the integrity of the Work, to agree with the Corresponding Author on all changes made to the Work during processing and editing.
19. In case of violation of their obligations under this Agreement, its parties bear the responsibility defined by this Agreement and the current legislation of Ukraine. All disputes under the Agreement are resolved through negotiations, and if the negotiations do not resolve the dispute – in the courts of the city of Kharkiv.
20. The parties are not responsible for the violation of their obligations under this Agreement, if it occurred through no fault of theirs. The party is considered innocent if it proves that it has taken all measures dependent on it for the proper fulfillment of the obligation.
21. The Co-authors are responsible for the truthfulness of the facts, quotes, references to legislative and regulatory acts, other official documentation, the scientific validity of the Work, all types of responsibility to third parties who have claimed their rights to the Work. The co-authors reimburse the University for all costs caused by claims of third parties for infringement of copyright and other rights to the Work, as well as additional material costs related to the elimination of identified defects.